Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128001031 | 12800103 | 1 | I | 2016 | 20160921 | 20160930 | 20160930 | EXP | GB-SYMPLMED PHARMACEUTICALS-2016SYMPLMED000326 | SYMPLMED PHARMACEUTICALS | 0.00 | Y | 0.00000 | 20160930 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128001031 | 12800103 | 1 | PS | PERINDOPRIL ERBUMINE. | PERINDOPRIL ERBUMINE | 1 | Oral | 8 MG, QD | Y | U | UNKNOWN | 20184 | 8 | MG | TABLET | ||||
| 128001031 | 12800103 | 2 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, QD | Y | U | UNKNOWN | 0 | 15 | MG | |||||
| 128001031 | 12800103 | 3 | C | CALCIUM W/COLECALCIFEROL | CALCIUMCHOLECALCIFEROL | 1 | Oral | 1.5 G, BID | U | UNKNOWN | 0 | 1.5 | G | ||||||
| 128001031 | 12800103 | 4 | C | MAGNESIUM GLYCEROPHOSPHATE | MAGNESIUM GLYCEROPHOSPHATE | 1 | Oral | 97.2 MG, BID | U | UNKNOWN | 0 | 97.2 | MG | ||||||
| 128001031 | 12800103 | 5 | C | PROPRANOLOL HYDROCHLORIDE. | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 80 MG, QD | U | UNKNOWN | 0 | 80 | MG | ||||||
| 128001031 | 12800103 | 6 | C | THIAMINE HYDROCHLORIDE. | THIAMINE HYDROCHLORIDE | 1 | Oral | 100 MG, QD | U | UNKNOWN | 0 | 100 | MG | ||||||
| 128001031 | 12800103 | 7 | C | NICOTINAMIDE W/RIBOFLAVIN/THIAMINE /00171501/ | 2 | Oral | 1 DF, QD | U | UNKNOWN | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 128001031 | 12800103 | 1 | Product used for unknown indication |
| 128001031 | 12800103 | 2 | Product used for unknown indication |
| 128001031 | 12800103 | 3 | Product used for unknown indication |
| 128001031 | 12800103 | 4 | Product used for unknown indication |
| 128001031 | 12800103 | 5 | Product used for unknown indication |
| 128001031 | 12800103 | 6 | Product used for unknown indication |
| 128001031 | 12800103 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 128001031 | 12800103 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 128001031 | 12800103 | Fall | |
| 128001031 | 12800103 | Fracture | |
| 128001031 | 12800103 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 128001031 | 12800103 | 1 | 20110626 | 20160823 | 0 | |
| 128001031 | 12800103 | 2 | 20110626 | 20160823 | 0 |